MEDULLARY thyroid carcinoma (MTC) may arise as
|
|
- Everett Watts
- 5 years ago
- Views:
Transcription
1 X/97/$03.00/0 Vol. 82, No. 10 Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright 1997 by The Endocrine Society A Case of Metastatic Medullary Thyroid Carcinoma: Early Identification Before Surgery of an RET Proto-Oncogene Somatic Mutation in Fine-Needle Aspirate Specimens* DIEGO RUSSO, FRANCO ARTURI, EUSEBIO CHIEFARI, DOMENICO MERINGOLO, DAVIDE BIANCHI, BARTOLOMEO BELLANOVA, AND SEBASTIANO FILETTI Cattedra di Endocrinologia, Dipartimento di Medicina Sperimentale e Clinica (F.A., S.F., E.C.), Cattedra di Farmacologia, Facoltà di Farmacia (D.R.), Università di Reggio Calabria, Via T. Campanella, Catanzaro, Italy; Unità Operativa di Endocrinologia (D.M., D.B.), Ospedale Bentivoglio; and Servizio di Medicina Nucleare Policlinico S. Orsola-Malpighi (B.B.), Bologna, Italy ABSTRACT Medullary thyroid carcinoma (MTC) management requires determination of the sporadic or familial nature of the disease. RET protooncogene mutation analysis in the tumor tissue obtained at surgery and in the peripheral blood identifies somatic vs. germinal mutations. We now report a case of MTC in which a RET somatic mutation at codon 918 was detected in fine-needle aspiration specimens obtained from both the thyroid nodule and two enlarged neck lymph nodes but Received March 21, Revision received June 3, Accepted June 19, Address all correspondence and requests for reprints to: Sebastiano Filetti, Cattedra di Endocrinologia, Dipartimento di Medicina Sperimentale e Clinica, Via T. Campanella, Catanzaro, Italy. filetti@mbox.vol.it. * This work was supported by a Ministero dell Università e delle Ricerca Scientifica e Tecnologica grant (40%) and by a grant of Associazione Italiana per la Ricerca sul Cancro (AIRC) (to S.F.). not in peripheral blood. Therefore, a diagnosis of sporadic MTC was made before surgery. Thus, this approach, by excluding preoperatively multiple endocrine neoplasia disease, permitted immediate thyroidectomy without search for pheochromocytoma. PCR-based genetic analysis in fine-needle aspiration biopsy specimens, therefore, preoperatively identifies genetic abnormalities at an early and easily manageable stage and may well contribute to the management strategy of MTC. (J Clin Endocrinol Metab 82: , 1997) MEDULLARY thyroid carcinoma (MTC) may arise as sporadic or familial disease, eventually occurring in association with other endocrine tumors in multiple endocrine neoplasia (MEN) syndrome 2A and 2B. In these inherited disorders, germline abnormalities (mostly point mutations) in the RET proto-oncogene have been identified in the majority of patients affected (1). Somatic RET mutations occur as well in sporadic MTC with a frequency variable between 25 and 70% in different studies (1, 2). Identification and assessment of the nature of the RET mutation (somatic or germinal) in all of the MTC is, therefore, a critical tool for discriminating sporadic cases from unrecognized familial disease and could replace biochemical screening based on the calcitonin (CT) serum level at basal concentrations and after pentagastrin stimulation (3, 4). This investigation was undertaken to assess the possibility of preoperative detection of genetic abnormalities in fine-needle aspiration specimens from a patient with MTC. A major problem in the management of these patients is the necessity of excluding the presence of a pheochromocytoma. In fact, the asymptomatic normotensive patient with MEN2 syndrome is at risk of dangerous and fatal paroxysms during surgery if an unsuspected pheochromocytoma is present (5). Thus, we report a case of a patient with a MTC presenting with enlarged neck lymph nodes. In this patient, we performed the RET proto-oncogene mutation analysis in the complementary DNA (cdna) from the fine-needle aspiration biopsy (FNAB) of the thyroid nodule and the lymph nodes, as well in the peripheral blood DNA. Case Report and Methods A 47-yr-old male was referred to us in April 1996 because of a right neck mass. Physical examination revealed several palpable enlarged lymph nodes in the right cervical and submandibular region and a 2-cm diameter nodule in the right thyroid lobe. Ultrasound evaluation confirmed the presence of a solid right thyroid mass (cold at 99 Tc scintigraphy) and of multiple enlarged lymph nodes in the right cervical region. Serum-free T 3 and TSH were normal. Subsequently, FNAB (under US guidance) on both the thyroid nodule and the enlarged lymph nodes was performed. An aspirate aliquot was smeared for cytological examination, and another was utilized for messenger RNA extraction. At cytology, diagnosis of suspected medullary carcinoma and lymph node metastases was made. High serum CT, 2800 ng/l (normal 0 10 ng/l) and carcinoembryonic antigen, 70 ng/ml (normal 0 5 ng/ml) levels confirmed the diagnosis of MTC. An accurate family history, extended to second-degree relatives, was negative for endocrine or neoplastic diseases. The presence of other neoplasia associated with the MTC in the MEN syndromes was excluded. In fact, there was no evidence of pheochromocytoma (by assessment of plasma and urinary catecholamines, by computerized tomographic scan of the abdomen, and scintigraphy by 131 I-labeled metaiodobenzylguanidine) or hyperparathyroidism (serum calcium and PTH levels in the normal range). The patient underwent total thyroidectomy and central neck lymph node dissection. Histological examination (kindly provided by Dr. C. Gallo) confirmed the diagnosis of MTC and MTC metastatic right cervical and submandibular lymph nodes; neither multifocal diseases or C cell hyperplasia were detected; immunohistochemistry 3378
2 RET MUTATION IN FNAB showed neoplastic cell positivity for CT and negativity for thyroglobulin (Fig. 1). Presence of amyloid was evident after staining with Congo red (Fig. 2). Genetic analysis RT-PCR amplification were performed as previously described (6). PCR conditions were the following: cycle 1 at 42 C for 15 min and 95 C for 15 sec; 40 cycles at 95 C (1 min), 61 C (1 min) and 72 C (1 min); the last cycle at 72 C for 7 min (42 total cycles) The following 39 and 59 oligonucleotides (from Genosys, Cambridge, UK) were used according to the published sequence of RET cdna (7): A) 10F (59-ATTGTTGGGGGACACGAG-39) sense primer; 11R (59-GCAGTGGATGCAGAAGGC-39) antisense primer. B) 12F (59-GCCGTGAAGATGCTGAAAGAG-39) sense primer; 14R (59-AAATGAGATGAGGTCGCCCAT-39) antisense primer. C) 15F (59-CTCGTTCATCGGGACTTGGCA39) sense primer; 17R (59-CCATACATCACTTTGCGTGGT-39) antisense primer. The amplification products were purified and examined by re- FIG. 1. Immunohistochemical staining of tumoral tissue. A, Immunostaining with anti-ct antibodies (immunoperoxidase) shows high positivity of tumoral cells. B, Immunostaining with antithyroglobulin antibodies (immunoperoxidase) shows high positivity of follicular peritumoral cells whereas tumoral cells are negative.
3 3380 RUSSO ET AL. JCE&M 1997 Vol 82 No 10 FIG. 2. Staining by Congo red shows presence of amyloid depots into tumoral cells. striction enzyme analysis and/or direct sequencing. Genomic DNA was extracted by 2 ml peripheral blood of the same patient using a blood DNA extraction kit (Qiagen, M Medical Genenco, Firenze, Italy). A search for RET gene abnormalities in exons 10, 11, 13, 14, and 16 was performed as described (8). Results The purified 198-bp DNA fragment, obtained by PCR amplification of a region containing codon 918 of exon 16 of the RET gene, which is the more frequently altered site in sporadic MTC (1, 2), was digested with Fok1. Figure 3 shows the presence of a stronger undigested band together with weak bands (of 156 and 42 bp), a pattern consistent with the loss of the Fok1 site in one allele of the gene. The same pattern was detected in the amplified cdna from FNAB of both the tumor and the lymph nodes (Fig. 3B). The nucleotide sequence of the same fragment confirmed the presence of an ATG to ACG heterozygotic mutation at codon 918 (Fig. 4). Analysis of genomic DNA extracted from peripheral blood of the same patient showed maintenance of the Fok1 site, revealing the somatic nature of the mutation (Fig. 3C). The other areas of the RET gene known to host abnormalities in familial medullary thyroid carcinoma (FMTC) or MEN2 patients were also examined in the FNAB specimens and blood DNA of the patient, showing absence of alterations (data not shown). Discussion MTC has a malignant clinical behavior. Regional lymph node metastases are often present at the diagnosis and are considered the most important prognostic factors (9). In approximately 20% of the cases, MTC is the primary manifestation of a MEN2 disease. In patients affected by MTC, therefore, evaluation of medullary adrenal gland and parathyroid function, as well as the assessment of a heritable disease, is required. Even without a suspicious family history, in fact, an inherited disease has been demonstrated in some cases by biochemical (10) or genetic screening (11). Recently, an alteration of RET proto-oncogene has been identified as the genetic marker of MEN 2A and 2B and hypothesized to be the causative event in such diseases. Point mutations of the RET gene occur also in sporadic MTC. Thus, new protocols for management of this illness using genetic analysis have been proposed (12, 13). In all of these protocols, the search for mutations in RET oncogene is first performed either in specimen obtained at surgery or, after the histological diagnosis, by DNA extraction from paraffin-embedded tissue blocks. Subsequently, if genetic analysis is positive, the search is extended to peripheral blood samples from the patients and eventually to their close relatives. In consideration of the rare possibility of coexistence of somatic and germinal alterations in different sites (14), the search for RET alterations must include all of the sites known to host genetic anomalies. However, at present, even after such a complete investigation, a 100% exclusion diagnosis for familial disease may be not reached (4). Our study shows the possibility and the feasibility to search for RET mutations at a very early stage, even before performing surgery, by analyzing the aspirates obtained from the thyroid nodule and enlarged neck lymph nodes, when present. In our patient the genetic analysis established a diagnosis of sporadic MTC, making it unnecessary for either familial screening with the traditional, not well-tolerated pentagastrin test or for further investigation for other endocrine neoplasia as part of a MEN2. In this regard, it appears as an important feature of our approach to exclude preoperatively the presence of MEN diseases in our patient
4 RET MUTATION IN FNAB 3381 FIG. 3. A, Restriction analysis of cdna derived PCR products of RET exon 16 after FokI digestion (3 h at 37 C). Samples were run on 2% agarose-tris-borate-etilendiamminetetraacetate gel containing ethidium bromide. Lane 1, Undigested amplicon from medullary carcinoma TT cell line; lane 2, digested amplicon from TT cells; lane 3, digested amplicon from patient s tumor; point mutation at codon 918 determines loss of FokI site leading to a pathological pattern. B, Restriction analysis of cdna- derived PCR products of RET exon 16 after FokI digestion. Lane 1, DNA size marker; lane 2, undigested amplicon from medullary carcinoma TT cell line; lane 3, digested amplicon from TT cells; lanes 4 and 5, Digested amplicons from cervical lymph node metastases of patient; point mutation at codon 918 determines loss of FokI site leading to a pathological pattern. C, Restriction analysis of blood DNA-derived PCR products of RET exon 16 after FokI digestion. Lane 1, DNA size marker; lane 2, undigested amplicon from unaffected individual; lane 3, digested amplicon from unaffected individual; lane 4, digested amplicon from patient; presence of a normal restriction pattern indicates absence of germinal mutations. with MTC. In fact, pheochromocytoma, even if asymptomatic, should be removed first, because its presence greatly increases the surgical risk during thyroidectomy (5). On the other hand, it is certainly difficult to exclude the presence of an asymptomatic pheochromocytoma by both hormonal assay and different imaging modalities, whereas the detection of a germline RET mutation would demonstrate the presence of MEN2 disease. In addition, detection of a RET mutation suggests a more careful follow up of a patient with sporadic MTC, even if the role of RET alterations as poor prognostic marker is still controversial (8, 15, 16). Considering both the feasibility and the accuracy of the genetic analysis, this approach may be excellent for staging patients and for monitoring the disease before surgery, as well to achieve or confirm a definitive diagnosis of MTC in the presence of a neck mass of unclear histology/cytology. Thus, PCR-based genetic analysis in of FNAB aspirates may represent a feasible and reliable tool in the management strategy of medullary thyroid carcinoma. References 1. Eng C The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung s disease. N Engl J Med. 335: Lips CJM, Hoppener JWM Molecular genetics and clinical implications of medullary thyroid carcinoma and mutations of the RET proto-oncogene. Curr Opin Endocrinol Diabetes. 5: Wohllk N, Cote GJ, Bugalho MMJ, et al Relevance of RET protooncogene mutations in sporadic medullary thyroid carcinoma. J Clin Endocrinol Metab. 81: Eng C, Clayton D, Schuffenecker I, et al The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2: international RET mutation consortium analysis. JAMA. 276:19: Cervi-Skinner SJ Case record of the Massachusetts General Hospital. N Engl J Med. 289: Arturi F, Russo D, Giuffrida D, et al Early diagnosis by genetic analysis of differentiated thyroid cancer metastases in small lymph nodes. J Clin Endocrinol Metab. 82: Takahashi M, Buma Y, Hiai H Isolation of RET proto-oncogene cdna with an amino-terminal signal. Oncogene. 4: FIG. 4. Presence of a point mutation in codon 918 of RET gene in DNA of tumoral tissue (coexistence of C and T as indicated by arrow).
5 3382 RUSSO ET AL. JCE&M 1997 Vol 82 No Fink M, Weinhausel A, Niederle B, Haas OA Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. Int J Cancer. 69: Duh QY, Sancho JJ, Greenspan FS, et al Medullary thyroid carcinoma. The need for early diagnosis and total thyroidectomy. Arch Surg. 124: Ponder BAJ, Finer N, Coffey R, et al Family screening in medullary thyroid carcinoma presenting without a family history. Q J Med. 67: Eng C, Mulligan LM, Smith DP, et al Low frequency of germline mutations in the RET proto-oncogene in patients with apparently sporadic medullary thyroid carcinoma. Clin Endocrinol (Oxf). 118: Ledger GA, Khosla S, Lindor NM, Thibodeau SN, Gharib H Genetic testing in the diagnosis and management of multiple endocrine neoplasia type II. Ann Intern Med. 122: Jhiang SM, Fithian L, Christopher M, et al RET mutation screening in MEN2 patients and discovery of a novel mutation in a sporadic medullary thyroid carcinoma. Thyroid. 6: Marsh DJ, Andrew SD, Eng C, et al Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma. Cancer Res. 56: Marsh DJ, Learoyd DL, Andrew SD, et al Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Clin Endocrinol (Oxf). 44: Romei C, Elisei R, Pinchera A, et al Somatic mutations of the RET proto-oncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metab. 81: The 25th Annual Meeting of the European Thyroid Association May 30 June 3, 1998 Athens, Greece For information, please contact: Prof. D.A. Koutras, Alexandra Hospital, 80 Vas. Sophias Avenue, Athens, Greece. Tel: ; Fax: A Local Meeting on Clinical Thyroidology with the participation of internationally esteemed scientists June 4, 1998 Athens, Greece For information, please contact: Prof. D. A. Koutras, Alexandra Hospital, 80 Vas. Sophias Avenue, Athens, Greece. Tel: ; Fax: Advances in Thyroid Eye Disease A Satallite Meeting of The 25th Annual Meeting of the European Thyroid Association May 28 29, 1998 Chalkidiki, Hellas For scientific organization and information; please contact: Dr. G.E. Krassas, MD, Associate Professor of Medicine, Endocrine Clinic Panagia Hospital, N. Plastira 22, N. Krini, Thessaloniki 55132, Hellas. Tel: ; Fax: Thyrotropin-Releasing-Hormone and Related Peptides on the Dawning of a New Millenium June 5 7, 1998 on the Island of Kos, Hellas For information contact: C/O Zita Congress, 46 Voulis Str., Athens, Hellas. Tel: ; Fax: Scientific Organization: Dr. L. Duntas, University of Athens, Evgenidion Hospital, 20 Papadiamantopoulou Str., Athens, Hellas. Tel: ; Fax:
Calcitonin. 1
Calcitonin Medullary thyroid carcinoma (MTC) is characterized by a high concentration of serum calcitonin. Routine measurement of serum calcitonin concentration has been advocated for detection of MTC
More informationMultiple endocrine neoplasia type 2B in a Chinese patient. Citation Hong Kong Medical Journal, 2004, v. 10 n. 3, p
Title Multiple endocrine neoplasia type 2B in a Chinese patient Author(s) Chang, A; Chan, WF; Lo, CY; Lam, KSL Citation Hong Kong Medical Journal, 2004, v. 10 n. 3, p. 206-209 Issued Date 2004 URL http://hdl.handle.net/10722/45152
More informationATA Guidelines for Medullary Thyroid Cancer: approach to initial management of sporadic and inherited disease
ATA Guidelines for Medullary Thyroid Cancer: approach to initial management of sporadic and inherited disease Richard T. Kloos, M.D. The Ohio State University Divisions of Endocrinology and Nuclear Medicine
More informationThyroid Nodules. Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA
Thyroid Nodules ENDOCRINOLOGY DIVISION ENDOCRINOLOGY DIVISION Dr. HAKIMI, SpAK Dr. MELDA DELIANA, SpAK Dr. SISKA MAYASARI LUBIS, SpA Anatomical Considerations The Thyroid Nodule Congenital anomalies Thyroglossal
More informationThyroid Nodules. Family Medicine Refresher Course Geeta Lal MD, FACS April 2, No financial disclosures
Thyroid Nodules Family Medicine Refresher Course Geeta Lal MD, FACS April 2, 2014 No financial disclosures Objectives Review epidemiology Work up of Thyroid nodules Indications for FNAB Evolving role of
More informationCarcinoma midollare tiroideo familiare
12 AME Italian Meeting 6 Joint Meeting with AACE Carcinoma midollare tiroideo familiare Profilo genetico e stratificazione del rischio Maria Chiara Zatelli Sezione di Endocrinologia Dipartimento di Scienze
More informationAPPROCCIO DIAGNOSTICO-TERAPEUTICO TERAPEUTICO AL CARCINOMA DIFFERENZIATO DELLA TIROIDE Sabato 6 aprile 2013 Aula Magna Nuovo Arcispedale S.
dal 1846 APPROCCIO DIAGNOSTICO-TERAPEUTICO TERAPEUTICO AL CARCINOMA DIFFERENZIATO DELLA TIROIDE Sabato 6 aprile 2013 Aula Magna Nuovo Arcispedale S. Anna Ruolo dell analisi genetica Maria Chiara Zatelli
More informationThyroid nodules 3/22/2011. Most thyroid nodules are benign. Thyroid nodules: differential diagnosis
Most thyroid nodules are benign Thyroid nodules Postgraduate Course in General Surgery thyroid nodules occur in 77% of the world s population palpable thyroid nodules occur in about 5% of women and 1%
More informationTHYROID CANCER IN CHILDREN. Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine
THYROID CANCER IN CHILDREN Humberto Lugo-Vicente MD FACS FAAP Professor Pediatric Surgery UPR School of Medicine Thyroid nodules Rare Female predominance 4-fold as likely to be malignant Hx Radiation exposure?
More informationUltrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events
Ultrasound-Guided Fine-Needle Aspiration of Thyroid Nodules: New events Sandrine Rorive, M.D., PhD. Erasme Hospital - Université Libre de Bruxelles (ULB) INTRODUCTION The assessment of thyroid nodules
More informationSodium±iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas
European Journal of Endocrinology (2000) 143 623±627 ISSN 0804-4643 CLINICAL STUDY Sodium±iodide symporter (NIS) gene expression in lymph-node metastases of papillary thyroid carcinomas F Arturi, D Russo
More informationGenetic Testing in Medullary Thyroid Carcinoma
Genetic Testing in Medullary Thyroid Carcinoma Presenter-Dr Sunil Malla Bujar Barua Moderator- Prof Gaurav Agarwal 1 Genetic testing in MTC 24/4/2012 Background 1959 Hazard et al first described MTC 1961
More informationTiming of Early Preventative Thyroidectomy in Children with MEN 2
Timing of Early Preventative Thyroidectomy in Children with MEN 2 Terry C. Lairmore, M.D. Professor of Surgery Director, Division of Surgical Oncology Texas Chapter of AACE Texas Endocrine Surgical Symposium
More informationCoexistence of parathyroid adenoma and papillary thyroid carcinoma. Yong Sang Lee, Kee-Hyun Nam, Woong Youn Chung, Hang-Seok Chang, Cheong Soo Park
J Korean Surg Soc 2011;81:316-320 http://dx.doi.org/10.4174/jkss.2011.81.5.316 ORIGINAL ARTICLE JKSS Journal of the Korean Surgical Society pissn 2233-7903 ㆍ eissn 2093-0488 Coexistence of parathyroid
More informationPage 289. Corresponding Author: Dr. Nitya Subramanian, Volume 3 Issue - 5, Page No
ISSN- O: 2458-868X, ISSN P: 2458 8687 Index Copernicus Value: 49. 23 PubMed - National Library of Medicine - ID: 101731606 SJIF Impact Factor: 4.956 International Journal of Medical Science and Innovative
More informationVolume 2 Issue ISSN
Volume 2 Issue 3 2012 ISSN 2250-0359 Correlation of fine needle aspiration and final histopathology in thyroid disease: a series of 702 patients managed in an endocrine surgical unit *Chandrasekaran Maharajan
More informationCase Scenario 1: Thyroid
Case Scenario 1: Thyroid History and Physical Patient is an otherwise healthy 80 year old female with the complaint of a neck mass first noticed two weeks ago. The mass has increased in size and is palpable.
More informationA KINDRED WITH a RET CODON Y791F MUTATION PRESENTING WITH HIRSCHSPRUNG S S DISEASE.
A KINDRED WITH a RET CODON Y791F MUTATION PRESENTING WITH HIRSCHSPRUNG S S DISEASE. ד"ר מרב פרנ קל ד גנית ברק גרוס דיויד פרופסור השרות לאנדוקרינ ולוגיה ומטבוליזם ירושלים ה דסה עין כר םם, Case Report 36
More informationInitial Lymph Node Dissection Increases Cure Rates in Patients with Medullary Thyroid Cancer
Original Article Initial Lymph Node Dissection Increases Cure Rates in Patients with Medullary Thyroid Cancer David Yü Greenblatt, Diane Elson, 1 Eberhard Mack and Herbert Chen, Departments of Surgery
More information3/29/2012. Thyroid cancer- what s new. Thyroid Cancer. Thyroid cancer is now the most rapidly increasing cancer in women
Thyroid cancer- what s new Thyroid Cancer Changing epidemiology Molecular markers Lymph node dissection Technical advances rhtsh Genetic testing and prophylactic surgery Vandetanib What s new? Jessica
More informationPEDIATRIC Ariel Katz MD
PEDIATRIC Ariel Katz MD Dept. Otolaryngology Head &Neck Surgery Wolfson Medical Center Holon, Israel OBJECTIVES Overview/Background Epidemiology/Etiology Intro to Guidelines Workup Treatment Follow-Up
More informationWTC 2013 Panel Discussion: Minimal disease
WTC 2013 Panel Discussion: Minimal disease Susan J. Mandel MD MPH Panelists Ken Ain Yasuhiro Ito Stephanie Lee Erich Sturgis Mark Urken Faculty/Presenter Disclosure Relationships with commercial interests
More informationDR.RUPNATHJI( DR.RUPAK NATH )
18. Screening for Thyroid Cancer Burden of Suffering Thyroid cancer accounts for an estimated 14,00 new cancer cases and more than 1,000 deaths in the U.S. each year. 1 The annual incidence is about 4/100,000
More informationDetecting Parathyroid Disease
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/detecting-parathyroid-disease/3078/
More informationCase Report Nonfunctional Metastatic Parathyroid Carcinoma in the Setting of Multiple Endocrine Neoplasia Type 2A Syndrome
Surgery Research and Practice, Article ID 731481, 4 pages http://dx.doi.org/10.1155/2014/731481 Case Report Nonfunctional Metastatic Parathyroid Carcinoma in the Setting of Multiple Endocrine Neoplasia
More informationPersistent & Recurrent Differentiated Thyroid Cancer
Persistent & Recurrent Differentiated Thyroid Cancer Electron Kebebew University of California, San Francisco Department of Surgery Objectives Risk factors for persistent & recurrent disease Causes of
More informationDr Catherine Woolnough, Hospital Scientist, Chemical Pathology, Royal Prince Alfred Hospital. NSW Health Pathology University of Sydney
Dr Catherine Woolnough, Hospital Scientist, Chemical Pathology, Royal Prince Alfred Hospital NSW Health Pathology University of Sydney Thyroid Cancer TC incidence rates in NSW Several subtypes - Papillary
More informationThyroid nodules - medical and surgical management. Endocrinology and Endocrine Surgery Manchester Royal Infirmary
Thyroid nodules - medical and surgical management JRE Davis NR Parrott Endocrinology and Endocrine Surgery Manchester Royal Infirmary Thyroid nodules - prevalence Thyroid nodules common, increase with
More informationNeoplasia 2018 lecture 11. Dr H Awad FRCPath
Neoplasia 2018 lecture 11 Dr H Awad FRCPath Clinical aspects of neoplasia Tumors affect patients by: 1. their location 2. hormonal secretions 3. paraneoplastic syndromes 4. cachexia Tumor location Even
More informationMEDULLARY THYROID CANCER and RELATED MEN SYNDROMES. Irina Kovatch, MD SUNY Downstate Medical Center Grand Rounds January 26 th, 2012
MEDULLARY THYROID CANCER and RELATED MEN SYNDROMES Irina Kovatch, MD SUNY Downstate Medical Center Grand Rounds January 26 th, 2012 Thyroid Cancer Comprises 95% of all endocrine malignancies and 1.5% of
More informationThyroglobulin Interference in the Determination of Thyroglobulin Antibody in Wash-Out Fluid from Fine Needle Aspiration Biopsy of Lymph Node
ORIGINAL ARTICLE Thyroglobulin Interference in the Determination of Thyroglobulin Antibody in Wash-Out Fluid from Fine Needle Aspiration Biopsy of Lymph Node Ibáñez N 1, Cavallo A.C 2, Smithuis F 1, Negueruela
More informationThyroid Cancer. With 51 Figures and 30 Tables. Springer
H.-J. Biersack F. Griinwald (Eds.) Thyroid Cancer With 51 Figures and 30 Tables Springer PART 1 Basics 1 The Changing Epidemiology of Thyroid Cancer 3 R. GORGES 1.1 Basic Epidemiological Problems in Thyroid
More informationThyroid Nodules. Hossein Gharib, MD, MACP, MACE
Thyroid Nodules Hossein Gharib, MD, MACP, MACE Professor of Medicine Mayo Clinic College of Medicine President Elect, American College of Endocrinology University Course January 2008 CP1294362-1 Thyroid
More informationMaria Chiara Zatelli Sezione di Endocrinologia e Medicina Interna Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università
Maria Chiara Zatelli Sezione di Endocrinologia e Medicina Interna Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università degli Studi di Ferrara Molecular markers? Endocrinology
More informationINDEX. Note: Page numbers of issue and article titles are in boldface type. cell carcinoma. ENDOCRINE SURGERY
ENDOCRINE SURGERY INDEX Note: Page numbers of issue and article titles are in boldface type. Adenylate cyclase, in signal transduction 425-426 Adrenal incidentalomas, 499-509 imaging of, 502-504 in patients
More informationProphylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2A
original article Prophylactic Thyroidectomy in Multiple Endocrine Neoplasia Type 2A Michael A. Skinner, M.D., Jeffrey A. Moley, M.D., William G. Dilley, Ph.D., Kouros Owzar, Ph.D., Mary K. DeBenedetti,
More informationMedullary Thyroid Cancer: Medullary Thyroid Cancer
Review & Update Nothing to disclose. Jessica E. Gosnell MD Assistant Professor in Residence Department of Surgery November 9, 2012 Medullary Thyroid Cancer MTC has distinct embryology, genetic association
More informationThyroid Nodule. Disclosure. Learning Objectives P A P A P A 3/18/2014. Nothing to disclose.
Thyroid Nodule Evaluating the patient with a thyroid nodule and some management options. Miguel V. Valdez PA C Disclosure Nothing to disclose. Learning Objectives Examination of thyroid gland Options for
More informationEvaluation and Management of Thyroid Nodules. Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada
Evaluation and Management of Thyroid Nodules Nick Vernetti, MD, FACE Palm Medical Group Las Vegas, Nevada Disclosure Consulting Amgen Speaking Amgen Objectives Understand the significance of incidental
More informationB. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life.
B. Environmental Factors. a. The major risk factor to papillary thyroid cancer is exposure to ionizing radiation, during the first 2 decades of life. b. Deficiency of dietary iodine: - Is linked with a
More informationMandana Moosavi 1 and Stuart Kreisman Background
Case Reports in Endocrinology Volume 2016, Article ID 6471081, 4 pages http://dx.doi.org/10.1155/2016/6471081 Case Report A Case Report of Dramatically Increased Thyroglobulin after Lymph Node Biopsy in
More informationThyroid nodules. Most thyroid nodules are benign
Thyroid nodules Postgraduate Course in General Surgery Jessica E. Gosnell MD Assistant Professor March 22, 2011 Most thyroid nodules are benign thyroid nodules occur in 77% of the world s population palpable
More informationSection 2 Original Policy Date 2013 Last Review Status/Date September 1, 2014
Policy Number 2.04.82 Molecular Markers in Fine Needle Aspirates of the Thyroid Medical Policy Section 2 Original Policy Date 2013 Last Review Status/Date September 1, 2014 Disclaimer Our medical policies
More information5/18/2013. Most thyroid nodules are benign. Thyroid nodules: new techniques in evaluation
Most thyroid nodules are benign Thyroid nodules: new techniques in evaluation Incidence Etiology Risk factors Diagnosis Gene classification system Treatment Postgraduate Course in General Surgery Jessica
More informationA variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study
ORIGINAL ARTICLE A variation in recurrence patterns of papillary thyroid cancer with disease progression: A long-term follow-up study Joon-Hyop Lee, MD, Yoo Seung Chung, MD, PhD,* Young Don Lee, MD, PhD
More informationNODULAR GOITRE EVALUATIONIN THE REGION OF THE HEALTHCARE CENTER OF NOVI PAZAR
48 MEDICINSKI GLASNIK / str. 48-57 Mersudin Mulić *, Bilsana Mulić NODULAR GOITRE EVALUATIONIN THE REGION OF THE HEALTHCARE CENTER OF NOVI PAZAR Summary: The term thyroid nodus refers to any irregular
More informationREPORT. Introduction. Dongbin Ahn 1, Jin Ho Sohn 1 and Ji Young Park 2
C A S E REPORT ISSN: 2005-162X J Korean Thyroid Assoc 2013 May 6(1): 80-84 http://dx.doi.org/10.11106/jkta.2013.6.1.80 A Case of Concurrent Papillary and Medullary Thyroid Carcinomas Detected as Recurrent
More informationGenetics and Genomics in Endocrinology
Genetics and Genomics in Endocrinology Dr. Peter Igaz MD MSc PhD 2 nd Department of Medicine Faculty of Medicine Semmelweis University Genetics-based endocrine diseases I. Monogenic diseases: Multiple
More informationWhat is Thyroid Cancer?
Thyroid Cancer What is Thyroid Cancer? The thyroid is a gland at the base of the throat near the trachea (windpipe). It is shaped like a butterfly, with a right lobe and a left lobe. The isthmus, a thin
More informationAn Unexpected Cause of Hypoglycemia
An Unexpected Cause of Hypoglycemia Stacey A. Milan, MD FACS Surgical Oncology Nothing to disclose Disclosures Objectives Identify indications for workup of hypoglycemia Define work up for hypoglycemic
More information- RET/PTC rearrangement: 20% papillary thyroid cancer - RET: medullary thyroid cancer
Thyroid Cancer UpToDate: Introduction: Risk Factors: Biology: Symptoms: Diagnosis: 1. Lenvina is the first line therapy with powerful durable response and superior PFS in pts with RAI-refractory disease.
More informationMedullary Thyroid Carcinoma. This case was provided by Treant Hospital, Bethesda, Hoogeveen, The Netherlands
Medullary Thyroid Carcinoma This case was provided by Treant Hospital, Bethesda, Hoogeveen, The Netherlands ADS-01504 Rev. 001 2016 Hologic, Inc. All rights reserved. Overview Medullary Thyroid Carcinoma
More informationChapter 14: Thyroid Cancer
The American Academy of Otolaryngology Head and Neck Surgery Foundation (AAO-HNSF) Presents... Chapter 14: Thyroid Cancer Daiichi Pharmaceutical Corporation, marketers and distributors of FLOXIN Otic (ofloxacin
More informationResult Navigator. Positive Test Result: RET. After a positive test result, there can be many questions about what to do next. Navigate Your Results
Result Navigator Positive Test Result: RET Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life
More informationDiagnostic Challenges in Multiple Endocrine Neoplasia Type 1 (MEN1) : Usefulness of Genetic Analysis
Diagnostic Challenges in Multiple Endocrine Neoplasia Type 1 (MEN1) : Usefulness of Genetic Analysis Professor R. V. Thakker, FRS May Professor of Medicine University of Oxford, U.K. Meet The Experts 49
More informationRossella Elisei. Department of Endocrinology, University Hospital, Pisa, Italy
Rossella Elisei Department of Endocrinology, University Hospital, Pisa, Italy THYROID CANCER IS RARE TUMOR AND REPRESENTS ONLY 3.8% OF ALL HUMAN TUMORS All human cancer Thyroid cancer MOST FREQUENT CANCER
More informationMulti-Organ Distant Metastases in Follicular Thyroid Cancer- Rare Case Report
Multi-Organ Distant Metastases in Follicular Thyroid Cancer- Rare Case Report Dr. Mohammed Raza 1, Dr. Sindhuri K 2, Dr. Dinesh Reddy Y 3 1 Professor, Department of Surgery, JSS University, Mysore, India
More information4/22/2010. Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey.
Management of Differentiated Thyroid Cancer: Head Neck Surgeon Perspective Hakan Korkmaz, MD Assoc. Prof. of Otolaryngology Ankara Dıșkapı Training Hospital-Turkey Thyroid gland Small endocrine gland:
More informationRunning Title: Utility of HCG Washout in Cervical LND FNA
AACE Clinical Case Reports Rapid Electronic Articles in Press Rapid Electronic Articles in Press are preprinted manuscripts that have been reviewed and accepted for publication, but have yet to be edited,
More informationMedullary Thyroid Cancer. Caroline S. Kim, MD Perelman School of Medicine at the University of Pennsylvania February 13, 2016
Medullary Thyroid Cancer Caroline S. Kim, MD Perelman School of Medicine at the University of Pennsylvania February 13, 2016 I have no disclosures 30 minutes on Medullary Thyroid Cancer (MTC) Classification
More informationDistant and Lymph Node Metastases of Thyroid Nodules with No Pathological Evidence of Malignancy: A Limitation of Pathological Examination
Endocrine Journal 2008, 55 (5), 889 894 Distant and Lymph Node Metastases of Thyroid Nodules with No Pathological Evidence of Malignancy: A Limitation of Pathological Examination YASUHIRO ITO, TOMONORI
More information2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines
2015 American Thyroid Association Thyroid Nodule and Cancer Guidelines Angela M. Leung, MD, MSc, ECNU November 5, 2016 Outline Workup of nontoxic thyroid nodule(s) Ultrasound FNAB Management of FNAB results
More informationA rare case of solitary toxic nodule in a 3yr old female child a case report
Volume 3 Issue 1 2013 ISSN: 2250-0359 A rare case of solitary toxic nodule in a 3yr old female child a case report *Chandrasekaran Maharajan * Poongkodi Karunakaran *Madras Medical College ABSTRACT A three
More informationCase 5: Thyroid cancer in 42 yr-old woman with Graves disease
Case 5: Thyroid cancer in 42 yr-old woman with Graves disease Giuliano Mariani Regional Center of Nuclear Medicine, University of Pisa Medical School, Pisa (Italy) Thyroid cancer in 42 yr-old woman with
More informationRisk Adapted Follow-Up
Risk Adapted Follow-Up Individualizing Follow- Up Strategies R Michael Tuttle, MD Clinical Director, Endocrinology Service Memorial Sloan Kettering Cancer Center Professor of Medicine Weill Medical College
More information5/1/2010. Genetic testing in patients with endocrine tumors. Genetic testing in Patients with Endocrine Tumors
Genetic testing in patients with endocrine tumors Why? Jessica E. Gosnell MD Assistant Prof of Surgery April 30, 2010 Genetic testing in Patients with Tumors Indications & Interpretation Germline mutations
More informationMedullary thyroid carcinoma: surgical treatment advances Gianlorenzo Dionigi a, Maria Laura Tanda b and Eliana Piantanida b
Medullary thyroid carcinoma: surgical treatment advances Gianlorenzo Dionigi a, Maria Laura Tanda b and Eliana Piantanida b a Department of Surgical Sciences and b Clinical Medicine, University of Insubria,
More informationThyroid Cancer: When to Treat? MEGAN R. HAYMART, MD
Thyroid Cancer: When to Treat? MEGAN R. HAYMART, MD ASSOCIATE PROFESSOR OF MEDICINE UNIVERSITY OF MICHIGAN MICHIGAN AACE 2018 ANNUAL MEETING Thyroid Cancer: When Not to Treat? FOCUS WILL BE ON LOW-RISK
More informationIndex. radiologic.theclinics.com. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A ACC. See Adrenal cortical carcinoma. Acromegaly and the pituitary gland, 551 Acute suppurative thyroiditis, 405, 406 Addison, Thomas and
More informationULTRASOUND GUIDED FNA: WHEN, HOW, AND WHY
ULTRASOUND GUIDED FNA: WHEN, HOW, AND WHY Marika Russell, MD, FACS Assistant Professor, UCSF OHNS Disclosures: none Overview Background Indications Technique Outcomes Survey Office-based ultrasound? USG-FNA?
More informationBiochemistry of Cancer and Tumor Markers
Biochemistry of Cancer and Tumor Markers The term cancer applies to a group of diseases in which cells grow abnormally and form a malignant tumor. It is a long term multistage genetic process. The first
More informationA Calcitonin-Negative Neuroendocrine Tumor Derived from Follicular Lesions of the Thyroid
Case Report Endocrinol Metab 2015;30:221-225 http://dx.doi.org/10.3803/enm.2015.30.2.221 pissn 2093-596X eissn 2093-5978 Calcitonin-Negative Neuroendocrine Tumor Derived from Follicular Lesions of the
More informationPRACTICE GUIDELINES: Thyroid Nodules and Cancer 2017 ESEO Alexandria
PRACTICE GUIDELINES: Thyroid Nodules and Cancer 2017 ESEO Alexandria James V. Hennessey MD Associate Professor of Medicine Harvard Medical School Case 1 28 year old woman sees OB for routine visit ROS:
More informationReoperative central neck surgery
Reoperative central neck surgery R. Pandev, I. Tersiev, M. Belitova, A. Kouizi, D. Damyanov University Clinic of Surgery, Section Endocrine Surgery University Hospital Queen Johanna ISUL Medical University
More informationFailure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think?
Annals of Surgical Oncology 15(1):293 301 DOI: 10.1245/s10434-007-9665-4 Failure to Recognize Multiple Endocrine Neoplasia 2B: More Common Than We Think? Curtis J. Wray, 1 Thereasa A. Rich, 1 Steven G.
More information40 TH EUROPEAN CONGRESS 0F CYTOLOGY LIVERPOOL, UK October 2-5, 2016
Outcomes from the diagnostic approach of thyroid lesions using US-FNA and LBC in clinical practice Emmanouel Mastorakis MD PhD Cytopathologist Director in Cytopathology Laboratory Regional General Hospital
More informationWhat is Thyroid Cancer? Here are four types of thyroid cancer:
What is Thyroid Cancer? Thyroid cancer is a group of malignant tumors that originate from the thyroid gland. The thyroid is a gland in the front of the neck. The thyroid gland absorbs iodine from the bloodstream
More informationCanadian Scientific Journal. Intraoperative color detection of lymph nodes metastases in thyroid cancer
Canadian Scientific Journal 2 (2014) Contents lists available at Canadian Scientific Journal Canadian Scientific Journal journal homepage: Intraoperative color detection of lymph nodes metastases in thyroid
More informationCitation Auris, nasus, larynx (2011), 38(3):
TitleManagement of metastasis to the thy Author(s) Ishikawa, Masaaki; Hirano, Shigeru; Citation Auris, nasus, larynx (2011), 38(3): Issue Date 2011-06 URL http://hdl.handle.net/2433/139807 Right 2010 Elsevier
More information5/3/2017. Ahn et al N Engl J Med 2014; 371
Alan Failor, M.D. Clinical Professor of Medicine Division of Metabolism, Endocrinology and Nutrition University of Washington April 20, 2017 No disclosures to report 1. Appropriately evaluate s in adult
More informationUltrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer
Ultrasound for Pre-operative Evaluation of Well Differentiated Thyroid Cancer Its Not Just About the Nodes AACE Advances in Medical and Surgical Management of Thyroid Cancer - 2017 Robert A. Levine, MD,
More informationSalivary Gland FNA ATYPICAL : Criteria and Controversies
Salivary Gland FNA ATYPICAL : Criteria and Controversies W.C. Faquin, M.D., Ph.D. Director, Head and Neck Pathology Massachusetts General Hospital Massachusetts Eye and Ear Infirmary Harvard Medical School
More informationThyroid Cancer (Carcinoma)
Information for Patients Thyroid Cancer (Carcinoma) Prepared by the American Association of Clinical Endocrinologists (AACE), a not-for-profit national organization of highly qualified specialists in hormonal
More informationThe Frozen Section: Diagnostic Challenges and Pitfalls
The Frozen Section: Diagnostic Challenges and Pitfalls William C. Faquin, M.D., Ph.D. Director, Head and Neck Pathology Massachusetts General Hospital & Massachusetts Eye and Ear Infirmary Harvard Medical
More informationSezione di Endocrinologia e Medicina Interna Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università degli Studi di Ferrara
Sezione di Endocrinologia e Medicina Interna Direttore: Prof. Ettore degli Uberti Dipartimento di Scienze Mediche Università degli Studi di Ferrara Endocrinology Overview of genetic markers Molecular markers
More informationOsman Ilkay Ozdamar, 1 Gul Ozbilen Acar, 1 Cigdem Kafkasli, 1 M. Tayyar Kalcioglu, 1 Tulay Zenginkinet, 2 and H. Gonca Tamer 3. 1.
Case Reports in Otolaryngology Volume 2015, Article ID 79658, 4 pages http://dx.doi.org/10.1155/2015/79658 Case Report Papillary Thyroid Microcarcinoma with a Large Cystic Dilated Lymph Node Metastasis
More informationWilms Tumor and Neuroblastoma
Wilms Tumor and Neuroblastoma Wilm s Tumor AKA: Nephroblastoma the most common intra-abdominal cancer in children. peak incidence is 2 to 3 years of age Biology somatic mutations restricted to tumor tissue
More information2748 jcem.endojournals.org J Clin Endocrinol Metab, August 2012, 97(8):
ORIGINAL Endocrine ARTICLE Care Long-Term Surveillance of Papillary Thyroid Cancer Patients Who Do Not Undergo Postoperative Radioiodine Remnant Ablation: Is There a Role for Serum Thyroglobulin Measurement?
More informationRepeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results
Anatomic Pathology / REPEAT THYROID FINE-NEEDLE ASPIRATION Repeat Thyroid Nodule Fine-Needle Aspiration in Patients With Initial Benign Cytologic Results Melina B. Flanagan, MD, MSPH, 1 N. Paul Ohori,
More information42 yr old male with h/o Graves disease and prior I 131 treatment presents with hyperthyroidism and undetectable TSH. 2 hr uptake 20%, 24 hr uptake 50%
Pinhole images of the neck are acquired in multiple projections, 24hrs after the oral administration of approximately 200 µci of I123. Usually, 24hr uptake value if also calculated (normal 24 hr uptake
More informationCase Report Simultaneous medullary thyroid carcinoma and pheochromocytoma: a case report of MEN2A
Int J Clin Exp Med 2016;9(6):12269-12274 www.ijcem.com /ISSN:1940-5901/IJCEM0021871 Case Report Simultaneous medullary thyroid carcinoma and pheochromocytoma: a case report of MEN2A Lei Zhao, Cheng Yang,
More informationGastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma
European Journal of Endocrinology (1999) 140 187 191 ISSN 0804-4643 Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma
More informationPre-operative Ultrasound of Lymph Nodes in Thyroid Cancer
Pre-operative Ultrasound of Lymph Nodes in Thyroid Cancer AACE - Advances in Medical and Surgical Management of Thyroid Cancer - 2018 Robert A. Levine, MD, FACE, ECNU Thyroid Center of New Hampshire Geisel
More informationPreoperative Evaluation
Preoperative Evaluation Lateral compartment lymph nodes are easier to detect and are amenable to FNA Central compartment lymph nodes are much more difficult to detect and FNA (Tg washout testing is compromised)
More informationManagement guideline for patients with differentiated thyroid cancer. Teeraporn Ratanaanekchai ENT, KKU 17 October 2007
Management guideline for patients with differentiated thyroid Teeraporn Ratanaanekchai ENT, KKU 17 October 2007 Incidence (Srinagarind Hospital, 2005, both sex) Site (all) cases % 1. Liver 1178 27 2. Lung
More informationOncologist. The. The Community Oncologist: Case Report. A Case of Advanced Medullary Thyroid Carcinoma Successfully Treated with Sunitinib
The Oncologist The Community Oncologist: Case Report A Case of Advanced Medullary Thyroid Carcinoma Successfully Treated with Sunitinib MARIA JOÃO BUGALHO, a c RITA DOMINGUES, b ALEXANDRA BORGES d a Serviço
More informationDisclosures. Parathyroid Pathology. Objectives. The normal parathyroid 11/10/2012
Disclosures Parathyroid Pathology I have nothing to disclose Annemieke van Zante MD/PhD Assistant Professor of Clinical Pathology Associate Chief of Cytopathology Objectives 1. Review the pathologic features
More informationNEOPLASMS OF THE THYROID PATHOLOGY OF PARATHYROID GLANDS. BY: Shifaa Qa qa
NEOPLASMS OF THE THYROID PATHOLOGY OF PARATHYROID GLANDS BY: Shifaa Qa qa Neoplasmas of the thyroid thyroid nodules Neoplastic ---- benign, malignant Non neoplastic Solitary nodules ----- neoplastic Nodules
More informationReview of Literatures
Review of Literatures Fine needle biopsy was popular in the Scandinavian countries some four decades ago. Though FNAC for any palpable tumor was first introduced in America in the 1920s by Martin, Ellis
More information